Storia: Simply Put: Tariffs on generics

WARPTECHNEWS · LAB

India's $30-billion pharma industry is staring at a fresh challenge after US President Donald Trump announced that generic medicines imported into the US would face tariffs of…

Simply Put: Tariffs on generics

Confronto fonti

Simply Put: Tariffs on generics

Timeline cronologica

Trump's 200% tariff plan may be a bitter pill for US consumers; Dr Reddy's warns of costlier medicines

Pharma companies in a flux over Trump's 200% tariff move on generics

Pharma companies in a flux over Trump's 200% tariff move on generics

India's pharma sector braces for impact of proposed Trump tariffs on generic drugs

‘Expect India to be concerned’: US official as Trump announces 200% tariffs on generic drugs

Tariff on generic drugs: Loud announcement, little consequence? 7 pharma stocks with upside potential of up…

U.S. to see higher generic drug prices thanks to tariffs, CEO of leading India pharma firm warns

Pharma stocks slide as Trump's 100% generic drug tariff plan spooks investors

Trump's 200% generic drug tariff threat puts $9.7 billion Indian pharma exports at risk; industry says reshoring not practical

'Completely out of scope': Experts weigh in on proposed US tariffs on generic drugs

‘Expect India to be concerned’: US official as Trump announces 200% tariffs on generic drugs

U.S. to see higher generic drug prices thanks to tariffs, CEO of leading India pharma firm warns

India's pharma sector braces for impact of proposed Trump tariffs on generic drugs

Simply Put: Tariffs on generics

US tariff proposal wake-up call for Indian pharma to diversify, innovate: Experts

Tariff on generic drugs: Loud announcement, little consequence? 7 pharma stocks with upside potential of up to 31%